In the above article [IIic K, Hawke RL, Thirumaran RK, Schuetz EG, Hull JH, Kashuba AD, Stewart PW, Lindley CM, and Chen ML (2013) Drug Metab Dispos 41:575–581; doi:10.1124/dmd.112.048108], the funding information is incomplete.
The correct funding information is as follows:
This work was supported by the National Institutes of Health National Institute of Allergy and Infectious Diseases [Grant 5-P30 A1050410]; and the Office of Women’s Health, U.S. Food and Drug Administration [Grant FRP#: FDA-SOL-05-00050]. K. I. was a drug research and development fellow (2006-2008) supported by GlaxoSmithKline.
The author regrets this error and any inconvenience it may have caused.